Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain-Reference-Cited by-同舟云学术

Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain

Published:2020-01-30 Issue:5 Volume:36 Page:399-416
ISSN:0742-2091
Container-title:Cell Biology and Toxicology
language:en
Short-container-title:Cell Biol Toxicol

Author:

Peng Shihong,Wang Jie,Chen Huang,Hu Pan,He Xiao-Long,He Yundong,Wang Minna,Tang Wenshu,He Qiurui,Wang Ying-Ying,Xie Jiayi,Guo Dandan,Ren Shancheng,Liu Mingyao,Qiu Wen-Wei,Yi Zhengfang^ORCID

Funder

National Key R&D Program of China

National Natural Science Foundation of China

Innovation program of Shanghai municipal education commission

the Fundamental Research Funds for the Central Universities

China Postdoctoral Science Foundation

The Science and Technology Commission of Shanghai Municipality

Shanghai Science and Technology Council

Shenzhen Municipal Government of China

ECNU Public Platform for Innovation

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Cell Biology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/s10565-020-09511-x.pdf

Reference48 articles.

1. Andersen RJ, Mawji NR, Wang J, Wang G, Haile S, Myung JK, et al. Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell. 2010;17(6):535–46. https://doi.org/10.1016/j.ccr.2010.04.027.

2. Antonarakis ES, Armstrong AJ, Dehm SM, Luo J. Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting. Prostate Cancer Prostatic Dis. 2016;19(3):231–41. https://doi.org/10.1038/pcan.2016.17.

3. Balk SP, Knudsen KE. AR, the cell cycle, and prostate cancer. Nucl Recept Signal. 2008;6:e001. https://doi.org/10.1621/nrs.06001.

4. Berlow RB, Dyson HJ, Wright PE. Expanding the paradigm: intrinsically disordered proteins and allosteric regulation. J Mol Biol. 2018;430(16):2309–20. https://doi.org/10.1016/j.jmb.2018.04.003.

5. Bray F, Lortet-Tieulent J, Ferlay J, Forman D, Auvinen A. Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer. 2010;46(17):3040–52. https://doi.org/10.1016/j.ejca.2010.09.013.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a small-molecule NDR1 agonist for prostate cancer therapy;Frontiers in Pharmacology;2024-02-12

2. Synthesis and Evaluation of Small Molecule Inhibitors of the Androgen Receptor N-Terminal Domain;ACS Medicinal Chemistry Letters;2023-11-17

3. Tricyclic Diterpenoids Selectively Suppress Androgen Receptor-Positive Prostate Cancer Cells;Molecules;2023-06-13

4. Current and emerging approaches to noncompetitive AR inhibition;Medicinal Research Reviews;2023-04-16

5. Targeting the N-terminal domain of the androgen receptor: The effective approach in therapy of CRPC;European Journal of Medicinal Chemistry;2023-02